afterwards, PSDV has jumped 15 percent during the last week. ALimare has dropped one percent. There should be room for some gains here .
Sentiment: Strong Buy
Food safety is an unsolved problem with an estimated 48 million foodborne illnesses occurring each year and costing over $50 billion.
PURE Bioscience is revolutionizing food safety with their heavily patented “SDC” and is positioned to become a leader in the food industry.
SDC has already been tested in several large restaurant chains and the results were significantly superior to all other methods. SDC is a powerful and extremely effective antimicrobial but it is safe to humans and has been granted the EPA’s safest product classification of a category IV.
LARGE RESTAURANT CHAINS are placing reorders that are expected to continue to increase to very sizeable numbers. PURE believes this is a 1.5 billion dollar market and SDC is far ahead of the competition.
Based on meetings with the USDA and the FDA, FOOD PROCESSORS are expected to be using SDC in 2015 to decontaminate produce and meat. SDC will also extend shelf life as well as reduce manufacturers costs. PURE believes this is billion-dollar market.
No other product can do what SDC does and do it safely.
SDC will dominate antimicrobials in hospitals, schools, homes, offices, markets, public places, cruise ships, airplanes, trains, personal products like soaps and everywhere the public gathers. Antimicrobial market for disease protection such as influenza, MRSA, etc. is another multi-billion dollar market
SDC is perfectly safe and it continues to kill dangerous pathogens for 24 hours EVEN AFTER IT DRIES.
PURE Bioscience is on the verge of delivering very large and fast growing revenues beginning this year and shares are trading between $1.10 and $1.20 with a very small market cap of $32 million.
All this information can be confirmed on YAHOO FINANCE under “PURE”
PURE is a Strong Buy and Hold
Sentiment: Strong Buy
Alimera closed on red numbers today, even after the green light in Italy for its intravitreal implant check this out http://finance.crwe-pr.com/2014/06/24/alimera-sciences-alim-agenzia-italiana-del-farmaco-oks-intravitreal-implant-for-chronic-diabetic-macular-edema/
Maryland, just curious why you post this on the ALIM MB? Biosilicon has very little to do with ALIM, it's a pSivida owned technology. It's good. It will be a game changer in the eye space and in other applications that need biologic sustained delivery.
The purpose of this work was to exploit the tunable
properties of BioSilicon (a form of oxidized porous silicon) as a
substrate to provide long term release Bevacizumab (Avastin).
BioSilicon can be manufactured with varying pore size and high
surface area. Proteins including antibodies, adsorb by a combination
of electrostatic, Van der Waals, and hydrophobic forces, while
changes in surface hydration, entropy, and protein structure (shape
and size) are also important. Strong electrostatic forces on the surface
not only enable the antibody to adsorb but also subsequently desorb
from the surface. In this work we evaluated the effect of pore size on
Avastin release over a period of three weeks
Oxidised porous silicon (OPS) was prepared with pore
sizes ranging from of 10 to 100nm (the hydrodynamic radii of
Avastin monomer estimated to be ~ 14.52nm). 5mg of OPS was
added to 25μL of a 25mg/mL Avastin stock solution (prepared from
the commercial formulation) and allowed to equilibrate overnight
at room temperature (22.5οC). 1975μL of Phosphate buffer saline
(PBS: pH7.4; 37οC) was added to the equilibrated OPS particles.
The suspension was then hand mixed for 10 seconds and centrifuged.
1mL of PBS was taken to calculate post loading concentration and
1mL of PBS was freshly added to the dissolution pot. Sampling
was performed every 24hrs for 20 days. Samples were analysed by
Size-Exclusion Chromatography coupled with UV and fluorescence
Maximal adsorption was obtained with OPS of average pore
size 25 to 30nm which provided approximately 12% (w/w) loading,
larger pores gave slightly less loading (10% at 50nm and 8% at
100nm) due to lower surface area. Material with a pore size of 10nm.
Same thoughts here. The Q1 result won't be good and that would be disclosed in about two weeks. the $35 million debt financing had already given us some clue to where the figure would be.
The NEW NDA will also be disclosed in the new 10-Q. the indication will be a much narrowed sub group. given the fact that all major indexes are at historical highs, a 50% hair cut is minimum. Remembering EXEL?
PURE Bioscience (PURE) found a new use for biotech that can quickly and safely kill pathogens that are dangerous to humans such as MRSA, influenza, HIV, E.coli, Salmonella, Norovirus, Hepatitis, Pneumonia, colds, Polio, deadly fungus, and most common infectious diseases.
AND THE SOLUTION IS SAFE, FAST, CHEAP AND EASY.
PURE Bioscience developed HEAVILY PATENTED “SDC” THAT KILLS ALL THE ABOVE-MENTIONED PATHOGENS AND YET IS PERFECTLY SAFE.
SDC is Silver Dihydrogen Citrate that has been infused with negative ions.
IT IS SIMPLY WIPED OR SPRAYED ON ANY SURFACE AND IT REMAINS ACTIVE FOR 24 HOURS.
Over 650 restaurants tested SDC on more than 1,000 data points and compared the efficacy of the chain's current sanitizer with that of PURE Hard Surface disinfectant and sanitizer and SDC was OVER 90% MORE EFFECTIVE.
SDC has also been successfully tested for food processing of meats and produce to destroy the dangerous pathogens such as E.coli, Salmonella, Norovirus and others and is expected to set the standard in the food industry.
THE EPA CLASSIFIES SDC WITH THEIR SAFEST RATING OF CATEGORY IV.
Also important is that SDC does not cause these dangerous pathogens to become resistant like antibiotics.
The World Health Organization estimates the cost of influenza epidemics to the economy at $71-167 billion per year.
The CDC estimates that each year, 48 million food borne illnesses from contaminated foods result in over $50 billion in losses from 128,000 hospitalizations, 3,000 deaths and very costly food recalls and lawsuits.
SDC will appeal to large markets such as the cruise industry, air travel, all public transportation, schools, hospitals, sporting events and essentially ALL PUBLIC PLACES.
SDC SALES ARE POSITIONED TO EXPLODE and PURE shares are only $1.20.
Sentiment: Strong Buy
Could go down even more after that. FDA is a captured, pay-to-play agency. If Apple, Amazon or Netflix had to go through an FDA-type agency how do you think that would have worked out? They would have never made it because the GE's, IBM's and CBS's of the world wouldn't have it. That's the environment small drug companies have to deal with at the FDA even if the drug has proven beneficial in other places in the world.
Fitz. He has no one to bully here. So, he comes to PSDV to impart his wisdom and authority in the bio's. After all, he knows and we're just junior idiots. He'll be careful to clarify all our misunderstandings. What a guy.
Hi Mack--Haven't looked at the ALIM MB in ages. Nothing of interest to read here. At least PSDV has some well informed investors who post on that MB. This is quite a dead zone. No wonder our friend and big-time(?) Alimera investor only posts on the PSDV MB. I suppose he believes there's no one here to school in biopharms in the eye care sector. So we get the benefit of his senior investing wisdom.